. 2021 Oct 29;13(21):5422. doi: 10.3390/cancers13215422

Table 3.

Additional treatment and follow-up.

Variable	All	BIR-to-SIR	BIR/Cure	p Value
n	83	34	49
Local recurrence, n (%)	17 (20.5%)	17 (50.0%)	-	-
LN recurrence, n (%)	9 (10.8%)	9 (26.5%)	-	-
Distant metastases, n (%)	14 (16.9%)	14 (42.4%)	-	-
Re-operation, n (%)	16 (19.3%)	15 (44.1%)	-	-
Additional I¹³¹, n (%)	60 (75.0%)	33 (97.1%)	27 (58.7%)	0.001
I¹³¹ cumulative dose, median (mCi)	288 (162.5350)	350 (300,450)	180 (150,300)	<0.001
External beam radiotherapy, n (%)	9 (11.0%)	8 (23.5%)	1 (2.1%)	<0.001
Death, n (%)	9 (10.8%)	7 (20.6%)	2 (4.1%)	0.180
Disease-related deaths n (%)	3 (3.6%)	3 (8.8%)	0 (0%)	0.104

LN, lymph node.